|
Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone
|
5
|
Resverlogix Corp.
|
May 30, 2017 11:13AM
|
|
Re: Resverlogix Receives Approval From The FDA Cardiovascular and Renal Division To Proceed With A Requested Apabetalone Clinical Trial
|
4
|
Resverlogix Corp.
|
May 15, 2017 05:17PM
|
|
Re: Resverlogix Repays $68.8 Million Loan
|
1
|
Resverlogix Corp.
|
Dec 07, 2017 12:00PM
|
|
Re: Resverlogix Special Meeting Jun 30 9am MDT
|
6
|
Resverlogix Corp.
|
Jul 01, 2015 11:28AM
|
|
Re: Resverlogix Special Meeting Jun 30 9am MDT
|
4
|
Resverlogix Corp.
|
Jul 01, 2015 11:35AM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
4
|
Resverlogix Corp.
|
Dec 02, 2019 10:55AM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
4
|
Resverlogix Corp.
|
Dec 02, 2019 11:46AM
|
|
Re: Resverlogix's Twitter Account....
|
2
|
Resverlogix Corp.
|
Nov 05, 2017 04:02PM
|
|
Re: Resverlogix’ BETonMACE Phase 3 Trial Successfully Reaches its Targeted 250 MACE Events
|
2
|
Resverlogix Corp.
|
Apr 18, 2019 02:55PM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
7
|
Resverlogix Corp.
|
Jun 14, 2020 11:56AM
|
|
Re: Richmond Club clarification please...
|
3
|
Resverlogix Corp.
|
Jun 27, 2015 02:30PM
|
|
Re: Richmond Club presentation
|
2
|
Resverlogix Corp.
|
Apr 03, 2016 07:48PM
|
|
Re: Richmond Club presentation
|
6
|
Resverlogix Corp.
|
Mar 30, 2016 04:47PM
|
|
Re: Richmond Club...
|
3
|
Resverlogix Corp.
|
Mar 24, 2016 03:40PM
|
|
Re: Risk vs Reward moving forward!
|
9
|
Resverlogix Corp.
|
Dec 17, 2021 05:28PM
|
|
Re: Rock Stars still rocking it
|
4
|
Zenith Epigenetics
|
Jun 13, 2018 03:45PM
|
|
Re: Rock Stars still rocking it
|
2
|
Zenith Epigenetics
|
Jun 05, 2018 03:35PM
|
|
Re: Rock Stars still rocking it
|
1
|
Zenith Epigenetics
|
Jun 06, 2018 02:43PM
|
|
Re: Rock Stars still rocking it
|
5
|
Zenith Epigenetics
|
Jun 06, 2018 04:01PM
|
|
Re: Rough Transcript - 2021_06_22_AGM
|
3
|
Resverlogix Corp.
|
Jun 22, 2021 06:22PM
|
